跳至主要内容
临床试验/NL-OMON51635
NL-OMON51635招募中2 期

Prospective clinical trial to evaluate the efficacy of acetazolamide for the treatment of cystoid macular edema in inherited retinal dystrophies: the CAR trial - The CAR trial

Amsterdam UMC0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 至 99(—)

入选标准

  • Eligible patients received a clinical diagnosis of IRD, and underwent at least
  • one clinical examination, in combination with one of the following
  • prerequisites:
  • IRD associated with causal genetic variant(s) (in e.g., USH2A, CRB1, RHO,
  • RP1, RP2, RPGR, PRPF31, or RS1 gene)
  • CME involving the fovea confirmed on spectral-domain optical coherence
  • tomography (OCT)

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Eyes will be excluded when the visual dysfunction is also significantly
  • associated with other ocular diseases besides the IRDs (e.g., glaucoma,
  • perforating trauma).
  • Patients treated with loop diuretics
  • Severe hepatic impairment
  • Severe renal insufficiency
  • Sodium and Potassium Depletion
  • Addison's disease
  • Hyperchloremic Acidosis
  • Cor pulmonale
  • Chronic non-congestive angle-closure glaucoma
  • The use of Acetazolamide
  • • Patients treated with interacting medication such as:
  • o Folic acid antagonists: methotrexate, trimethoprim and pyrimethamine
  • o Hypoglycaemics
  • o Oral anti-coagulants
  • o Cardiac glycosides: digoxine
  • o diuretics, such as thiazides and loop diuretics:
  • o anticonvulsants such as: phenytoin, primidone and carbamazepine
  • o Carbonic Anhydrase Inhibitors
  • o Sodium hydrogen carbonate
  • o Cyclosporine
  • o Ephedrine, methadone, amphetamine, quinidine and lithium

研究者

发起方
Amsterdam UMC

相似试验